Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-01-02 @ 3:35 AM
Study NCT ID:
NCT06439056
Status:
COMPLETED
Last Update Posted:
2025-09-23
First Post:
2024-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
Sponsor:
Nanexa AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NEX-22-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |